In two independent mouse models of AD, rapamycin, through inhibition of mTOR signaling, rescued cognitive deficits by suppressing extracellular Aβ deposition and intracellular tau accumulation [45,63]. This evidence concerns the gene MAPT and Alzheimer disease.